Maria V. Barron
Director of Finance/CFO at The Art Institute of Fort Lauderdale
Maria V. Barron active positions
| Companies | Position | Start | End |
|---|---|---|---|
The Art Institute of Fort Lauderdale
 The Art Institute of Fort Lauderdale Other Consumer ServicesConsumer Services The Art Institute of Fort Lauderdale (AiFL) was established in September1968 and provides training for a wide variety of professional fields involving the creative arts. The school's career-oriented curriculum offers bachelor's degrees, associate degrees and diplomas in everything from advertising and broadcasting to photography and yacht design. The college is one of a member institutions in The Art Institutes System which is a subsidiary of Education Management Corporation. | Chief Administrative Officer | - | - |
| Director of Finance/CFO | - | - |
Career history of Maria V. Barron
Former positions of Maria V. Barron
| Companies | Position | Start | End |
|---|---|---|---|
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Chief Administrative Officer | 2010-09-30 | 2013-11-17 |
Statistics
International
| United States | 3 |
Operational
| Chief Administrative Officer | 2 |
| Director of Finance/CFO | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
- Stock Market
- Insiders
- Maria V. Barron
- Experience
